A Multicenter Observational Cohort Study to Evaluate the Effects of Bisphosphonate Exposure on Bone Mineral Density and Other Health Outcomes in Osteogenesis Imperfecta-Reference-Cited by-同舟云学术

A Multicenter Observational Cohort Study to Evaluate the Effects of Bisphosphonate Exposure on Bone Mineral Density and Other Health Outcomes in Osteogenesis Imperfecta

Published:2019-01-07 Issue:5 Volume:3 Page:e10118
ISSN:2473-4039
Container-title:JBMR Plus
language:en
Short-container-title:JBMR Plus

Author:

Bains Jaskaran S¹,Carter Erin M¹,Citron Kate P¹,Boskey Adele L¹,Shapiro Jay R²,Steiner Robert D³⁴,Smith Peter A⁵,Bober Michael B⁶,Hart Tracy⁷,Cuthbertson David⁸,Krischer Jeff⁸,Byers Peter H⁹,Pepin Melanie⁹,Durigova Michaela¹⁰,Glorieux Francis H¹⁰,Rauch Frank¹⁰,Sliepka Joseph M¹¹,Sutton V Reid¹¹¹²,Lee Brendan¹¹¹²,Nagamani Sandesh CS¹¹¹²,Raggio Cathleen L¹,

Affiliation:

1. Hospital for Special Surgery; Dept of Orthopedic Surgery; New York NY USA

2. Department of Bone and Osteogenesis Imperfecta; Kennedy Krieger Institute; Baltimore MD USA

3. Departments of Pediatrics and Molecular and Medical Genetics; Oregon Health & Science University; Portland OR USA

4. University of Wisconsin School of Medicine and Public Health; Madison WI USA

5. Shriners Hospitals for Children; Chicago; IL USA

6. Division of Medical Genetics; Alfred I. DuPont Hospital for Children; Wilmington DE USA

7. Osteogenesis Imperfecta Foundation; Gaithersburg; MD USA

8. College of Medicine; University of South Florida, Biostatistics; Tampa FL USA

9. Departments of Medicine and Pathology; Division of Medical Genetics; University of Washington; Seattle WA USA

10. Shriners Hospital for Children-Canada and McGill University, Division of Endocrinology; Montreal; QC Canada

11. Department of Molecular and Human Genetics; Baylor College of Medicine; Houston TX USA

12. Texas Children's Hospital, Human Genetics; Houston TX USA

Funder

Brittle Bone Disease Consortium

Office of Rare Diseases Research

NCATS

National Institute of Arthritis and Musculoskeletal and Skin Diseases

National Institute of Dental and Craniofacial Research

Eunice Kennedy Shriver National Institute of Child Health and Human Development

Osteogenesis Imperfecta Foundation

Clinical Translational Core of Baylor College of Medicine IDDRC

Doris Duke Charitable Foundation

Publisher

Wiley

Subject

Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/jbm4.10118/fullpdf

Reference26 articles.

1. Osteogenesis imperfecta;Forlino;Lancet (London, England),2016

2. Pharmacological and biological therapeutic strategies for osteogenesis imperfecta;Marom;Am J Med Genet C Semin Med Genet,2016

3. Genetic heterogeneity in osteogenesis imperfecta;Sillence;J Med Genet,1979

4. Advances in the classification and treatment of osteogenesis imperfecta;Thomas;Curr Osteoporos Rep,2016

5. A cross-sectional multicenter study of osteogenesis imperfecta in North America-results from the linked clinical research centers;Patel;Clin Genet,2015

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging Landscape of Osteogenesis Imperfecta Pathogenesis and Therapeutic Approaches;ACS Pharmacology & Translational Science;2024-01-02

2. Combination of osteogenesis imperfecta and hypophosphatasia in three children with multiple fractures, low bone mass and severe osteomalacia, a challenge for therapeutic management;European Journal of Medical Genetics;2023-11

3. Association of trabecular bone score and bone mineral apparent density with the severity of bone fragility in children and adolescents with osteogenesis imperfecta: A cross-sectional study;PLOS ONE;2023-08-29

4. Pharmacological options in the treatment of osteogenesis imperfecta: A comprehensive review of clinical and potential alternatives;Biochemical Pharmacology;2023-07

5. Targeting strategies for bone diseases: signaling pathways and clinical studies;Signal Transduction and Targeted Therapy;2023-05-17